News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
530 Results
Type
Article (52)
Press Release (478)
Section
Business (174)
Deals (27)
Drug Development (38)
FDA (19)
Job Trends (7)
News (251)
Policy (27)
Tag
Alliances (13)
Alzheimer's disease (1)
Approvals (16)
Autoimmune disease (1)
Best Places to Work (7)
Biosimilars (7)
Cancer (2)
Cardiovascular disease (3)
Clinical research (34)
Collaboration (3)
Complete response letters (2)
COVID-19 (2)
Data (1)
Diabetes (1)
Drug discovery (1)
Earnings (123)
Events (129)
Executive appointments (2)
FDA (18)
GLP-1 (2)
Government (3)
Healthcare (10)
Immunology and inflammation (2)
Infectious disease (3)
Inflammatory bowel disease (1)
Intellectual property (2)
IPO (16)
Job creations (1)
Layoffs (2)
Legal (12)
Lymphoma (1)
Mergers & acquisitions (18)
Metabolic disorders (1)
Multiple sclerosis (3)
Neuroscience (5)
Non-profit (1)
Northern California (2)
Obesity (1)
Patents (2)
People (43)
Phase I (1)
Phase II (13)
Phase III (19)
Pipeline (3)
Postmarket research (3)
Preclinical (1)
Rare diseases (1)
Real estate (2)
Regulatory (16)
Reports (1)
Schizophrenia (1)
Southern California (1)
Startups (3)
Supply chain (1)
United States (32)
Vaccines (1)
Weight loss (1)
Date
Last 7 days (1)
Last 30 days (8)
Last 365 days (94)
2025 (22)
2024 (104)
2023 (105)
2022 (141)
2021 (102)
2020 (50)
2019 (4)
2013 (1)
Location
Asia (19)
Australia (2)
California (4)
Canada (3)
Europe (103)
Japan (1)
Massachusetts (1)
New Jersey (2)
New York (2)
Northern California (2)
Pennsylvania (14)
Southern California (1)
Tennessee (6)
Texas (3)
530 Results for "viatris".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Idorsia and Viatris update their collaboration for selatogrel and cenerimod
February 26, 2025
·
4 min read
Patents
Novo, Viatris Settle Ozempic Patent Row
Alongside the settlement, Novo and Viatris have asked the U.S. Patent and Trademark Office to terminate its review of the validity of the Danish drugmaker’s semaglutide patents.
October 8, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Viatris to Present at the Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
1 min read
Press Releases
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025
·
5 min read
Press Releases
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
February 27, 2025
·
46 min read
Press Releases
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 3, 2025
·
1 min read
Press Releases
Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Pharm Country
Viatris to Participate in the Jeffries Global Healthcare Conference
Viatris Inc. today announced the company will participate in the Jeffries Global Healthcare Conference at the Marriott Marquis Hotel in New York, NY on Thursday, June 6, 2024.
May 31, 2024
·
1 min read
Press Releases
Viatris Announces Third Quarter 2024 Dividend
November 5, 2024
·
4 min read
Business
Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024
Viatris Inc. (NASDAQ: VTRS) will report its second quarter 2024 financial results on Thursday, August 8, 2024, before the open of the U.S. financial markets.
June 7, 2024
·
1 min read
1 of 53
Next
